Mexedia secures €20M equity line from Likan AG to fund acquisition push
What's the deal? Italy's MexediaDealroom has a profile for this one. Try Dealroom → has signed an agreement with Swiss firm Likan AGDealroom has a profile for this one. Try Dealroom → for a reserved capital increase of up to €20 million, priced at a fixed €1.00 per share. The deal, approved by shareholders on October 28, 2026, will be executed in tranches over 12 months on a best-efforts basis.
How it works: Likan subscribed and fully paid a first tranche of €1 million on signing, issuing 1,000,000 new ordinary shares. It has committed to subscribe €2.5 million within the first 90 days, with later tranches of €250,000 to €2 million drawn at Mexedia's discretion. A fee equal to 10% of amounts actually funded is payable to a company designated by the investor.
What's the endgame? Mexedia, listed on Euronext Growth Paris, has reshaped itself into an industrial holding company after a 2026 reorganisation that brought Stantup ServiceDealroom has a profile for this one. Try Dealroom → into the group. Proceeds are earmarked for external growth through new equity investments, plus support for subsidiaries and capital strengthening. The company has not yet committed to any specific acquisition.
Why now? The financing follows a year of restructuring. Mexedia acquired 51% of Stantup Service for €16.5 million and cut net debt to €4.3 million at June 30, down from €34.7 million at the end of 2025.
"The agreement with Likan AG provides Mexedia with a capital facility on predetermined terms, to be drawn according to actual needs and growth opportunities," said chief executive officer Paolo Bona. He added that the resources would mainly fund "stakes in companies with recurring revenues, positive profitability and real synergies with the group."
What could go wrong? The facility is dilutive: up to 20 million new shares could be issued, potentially 70.54% of post-transaction capital. The €1.00 subscription price marked a 67.43% discount to the prior close, and because the commitment is best-efforts, full funding is not guaranteed.
The signal: This is less a conventional cash raise than a flexible, deeply discounted financing line built to fuel Mexedia's shift toward an acquisition-focused holding model. Execution and dilution — not the headline €20 million — will decide whether the strategy pays off.
Read more: finanznachrichten.de
Image credit: Generated with Gemini
